Sogn Arena (map)
Klaus Torgårds vei 3, 2. etg
Women's fat has a more active metabolism, but this effect disappears later in life.
NCMM congratulates NCMM Associate Investigator and Board Member, Hilde Loge Nilsen, and colleague Evandro Fei Fang on their recent research which has found that the clearance of dysfunctional mitochondria slows down the progression of Alzheimer’s Disease
Gareth Sullivan and his research group has been selected as one of the academic communities that will help solve the challenges of growing environmentally friendly and ethical meat at an affordable price. For good measure, they may also save endangered species of animals. The news was published in Nature on 6 February.
The group's latest publication features in JoVE (The Journal of Visualized Experiments)
Newly appointed Director of NCMM, Professor Janna Saarela, gave a welcome talk to staff on Wednesday 9 January.
A drug development project started by the Taskén Group at NCMM is at the centre of a new and unique co-development agreement between a Norwegian start-up and an Indian pharmaceutical company.
See Julia Kristevas Honorary Lecture at the conference "Cultural crossings of care", October 26 2018.
Hybrid Technology Hub researcher Jo Waaler is awarded a grant of 4,4 million NOK for the project Tankyrase Inhibition in Cancer Immunotherapy. The grant is awarded by Helse Sør Øst.
The preparation for the new, major international postdoctoral programme – Scientia Fellows II – has started. The EU grant provides 250 new person years at the faculty.
Unlike Sweden, Denmark and Finland, Norway currently does not have a dedicated cryo electron microscopy facility for single particle analysis. We interviewed NCMM’s Acting Director, Hartmut Luecke, and researcher Eva Cunha, about their experiences with using cryo-EM and the current plans to bring the technology to Norway.
Dr Mathelier, head of the Computational Biology and Gene Regulation Group at NCMM, has been awarded a prestigious grant by the Research Council of Norway.
Congratulations to the Mathelier Group on their recent publication in the journal Nucleic Acids Research. PhD student in the Mathelier Group, Marius Gheorghe, is first author on the paper.
Now the spring’s courses on the postdoctoral programme and the School of Health Innovation are open for registration.
Under you will find some practical information on opening hours and availability of the different administrative services at the institute during the Christmas holidays.
New study on the association between phenotypic characteristics, pattern of UV radiation exposure, and risk of melanoma on different body sites.
Sunbathing vacation before age 20 years was associated with significantly increased risk of melanoma on legs. This highlights the importance of starting sun protection early in life.
Reza Ghiasvand in an interview by MedicalResearch.com
Sandra Lopez-Aviles and Anthony Mathelier both awarded grants as part of Norwegian Cancer Society’s annual open call.
Former NCMM Director, Professor Kjetil Taskén, features in an article about the history of patents in research, and the pros and cons associated with the practice.
SPARK Norway is UiO:Life Science’s innovation programme for health-related life sciences. Meet three of the SPARKees in our new videos and get inspired to submit your application by 15 November.
The University of Oslo has recruited Dr Janna Saarela, Research Director of Institute for Molecular Medicine Finland (FIMM), the Finnish node of the Nordic EMBL Partnership, as the new Director of Centre for Molecular Medicine Norway (NCMM).
Dr. Michael Hawrylycz from the Allen Institute gave a lecture on his research on brain atlases at the IMB Distinguished Seminar on October 5.
It was curiosity about the Human Brain Project that enticed the acclaimed researcher to come to Norway.
EU-OPENSCREEN officially recognised as European Research Infrastructure Consortium (ERIC)
Annual event provides important networking opportunities for EATRIS
NCMM congratulates Professor Jens Petter Berg on his appointment as the new Dean of Research at the Faculty of Medicine, University of Oslo
The Nordic EMBL Partnership is very pleased to announce that Professor Poul Nissen, Director of DANDRITE (Danish Research Institute of Translational Neuroscience) has been named as the third speaker of the Nordic EMBL Partnership.